Algert Global LLC Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Algert Global LLC decreased its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 88.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,962 shares of the company’s stock after selling 15,244 shares during the quarter. Algert Global LLC’s holdings in Neurocrine Biosciences […]

Leave a Reply

Your email address will not be published.

Previous post Algert Global LLC Buys 8,720 Shares of Codexis, Inc. (NASDAQ:CDXS)
Next post Truist Financial Cuts Privia Health Group (NASDAQ:PRVA) Price Target to $28.00